A federal district court in Pennsylvania entered Jan. 31 a consent judgment in favor of BioTelemetry declaring that defendants, led by Mednet Healthcare Technologies Inc., infringed the company’s patents related to its cardiac system (CardioNet, LLC v. Mednet Healthcare Techs., Inc., E.D. Pa., 2:12-cv-02517-JS, 1/31/14).
After the consent judgment filing, BioTelemetry purchased Mednet.
BioTelemetry (formerly CardioNet) sued in May 2012, alleging that Mednet’s Heartrak External Cardiac Ambulatory Telemetry (ECAT) system infringed five patents associated with its CardioNet Mobile Cardiac Outpatient Telemetry (MCOT) system. The CardioNet MCOT system provides the next-generation ambulatory cardiac monitoring service with beat-to-beat, real-time ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.